Clinical trial
Safety Study of TroVax Alone vs. TroVax Plus Interferon Alpha in Patients With…
NCT00445523 · The Methodist Hospital Research Institute, Other · Completed
Key facts
| NCT number | NCT00445523 |
|---|---|
| Title | Safety Study of TroVax Alone vs. TroVax Plus Interferon Alpha in Patients With Renal Cancer |
| Official title | A Phase II Trial to Assess the Activity of TroVax® Alone vs. TroVax® Plus Interferon Alfa (IFN-α) on Patients With Advanced or Metastatic Renal Cell Cancer |
| Lead sponsor | The Methodist Hospital Research Institute, Other |
| Collaborators | Oxford BioMedica Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Carcinoma, Renal Cell |
| Intervention type | Biological, Drug |
| Interventions | TroVax® (Immunological Vaccine Therapy), Interferon-alpha |
| Enrollment | 28 |
| Start date | May 1, 2006 |
| Primary completion | Jan 1, 2008 |
| Completion | Feb 1, 2008 |
| First posted | Mar 9, 2007 |
| Last update posted | Mar 17, 2016 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: